HomeCompareETNB vs NNN

ETNB vs NNN: Dividend Comparison 2026

ETNB yields 13.48% · NNN yields 5.68%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ETNB wins by $23.0K in total portfolio value
10 years
ETNB
ETNB
● Live price
13.48%
Share price
$14.84
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$48.5K
Annual income
$3,111.66
Full ETNB calculator →
NNN
NNN REIT Inc.
● Live price
5.68%
Share price
$41.89
Annual div
$2.38
5Y div CAGR
8.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.6K
Annual income
$2,637.42
Full NNN calculator →

Portfolio growth — ETNB vs NNN

📍 ETNB pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodETNBNNN
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ETNB + NNN cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ETNB pays
NNN pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ETNB
Annual income on $10K today (after 15% tax)
$1,145.55/yr
After 10yr DRIP, annual income (after tax)
$2,644.91/yr
NNN
Annual income on $10K today (after 15% tax)
$482.93/yr
After 10yr DRIP, annual income (after tax)
$2,241.81/yr
At 15% tax rate, ETNB beats the other by $403.10/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ETNB + NNN for your $10,000?

ETNB: 50%NNN: 50%
100% NNN50/50100% ETNB
Portfolio after 10yr
$37.0K
Annual income
$2,874.54/yr
Blended yield
7.76%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ETNB right now

ETNB
Analyst Ratings
9
Buy
6
Hold
Consensus: Buy
Price Target
$17.17
+15.7% upside vs current
Range: $12.00 — $25.00
Altman Z
12.5
Piotroski
2/9
NNN
Analyst Ratings
10
Buy
15
Hold
4
Sell
Consensus: Hold
Price Target
$44.93
+7.3% upside vs current
Range: $43.00 — $48.50
Altman Z
1.1
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ETNB buys
0
NNN buys
0
No recent congressional trades found for ETNB or NNN in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricETNBNNN
Forward yield13.48%5.68%
Annual dividend / share$2.00$2.38
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%8.6%
Portfolio after 10y$48.5K$25.6K
Annual income after 10y$3,111.66$2,637.42
Total dividends collected$22.0K$13.7K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusBuyHold
Analyst price target$17.17$44.93

Year-by-year: ETNB vs NNN ($10,000, DRIP)

YearETNB PortfolioETNB Income/yrNNN PortfolioNNN Income/yrGap
1← crossover$12,048$1,347.71$10,737$617.02+$1.3KETNB
2$14,409$1,517.46$11,577$710.93+$2.8KETNB
3$17,113$1,696.08$12,538$822.59+$4.6KETNB
4$20,194$1,882.68$13,645$956.06+$6.5KETNB
5$23,684$2,076.25$14,925$1,116.51+$8.8KETNB
6$27,617$2,275.75$16,415$1,310.57+$11.2KETNB
7$32,031$2,480.12$18,158$1,546.77+$13.9KETNB
8$36,961$2,688.28$20,213$1,836.20+$16.7KETNB
9$42,447$2,899.14$22,649$2,193.37+$19.8KETNB
10$48,530$3,111.66$25,558$2,637.42+$23.0KETNB

ETNB vs NNN: Complete Analysis 2026

ETNBStock

89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also intends to develop pegozafermin for the treatment of severe hypertriglyceridemia. 89bio, Inc. was incorporated in 2018 and is headquartered in San Francisco, California.

Full ETNB Calculator →

NNNREIT

National Retail Properties invests primarily in high-quality retail properties subject generally to long-term, net leases. As of September 30, 2020, the company owned 3,114 properties in 48 states with a gross leasable area of approximately 32.4 million square feet and with a weighted average remaining lease term of 10.7 years.

Full NNN Calculator →
📬

Get this ETNB vs NNN comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ETNB vs SCHDETNB vs JEPIETNB vs OETNB vs KOETNB vs MAINETNB vs ADCETNB vs EPRTETNB vs FCPT

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.